A German cannabis wholesaler and distributor has announced that they have become the first European company to import medical cannabis products from Latin America for preliminary testing.
On Wednesday, Frankfurt-based Cansativa revealed that they would be importing a variety of cannabis flower and extract products from Uruguay and Colombia to be tested by independent German laboratories for heavy metals, pesticides, and other contaminants.
In 2013, Uruguay became the first country in the world to completely legalize marijuana, though sales did not begin until July of 2017.
“The importation of medical cannabis paves the way and brings us one step closer to commercializing medical cannabis in Germany,” said Cansativa Co-Founder, Benedikt Sons in a statement. “It also highlights our extensive reach and ability to import medical cannabis products from countries other than the Netherlands and Canada.”
Sons says that they chose Fotmer Life Sciences, which has facilities in Nueva Helvecia, Uruguay, and Clever Leaves in Bogota, Colombia because the two companies have demonstrated “deep understanding of the science” behind cannabis cultivation and can produce medical marijuana that meets the high standards required to enter the European market.
Clever Leaves CEO, Andrés Fajardo says that his company is able to make scientific advancements that will define the worldwide cannabis market.
Clever Leaves anticipates becoming the world’s largest medical cannabis grower by 2023, utilizing more than 10 million square feet of growable terrain to produce the lowest-cost pharmaceutical-grade cannabis oil anywhere.
Founded in 2017, Cansativa is one of the largest importers and distributors of medical cannabis products to pharmacies and pharmaceutical wholesalers throughout Germany.
